Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Total Current Liabilities (2019 - 2025)

Burning Rock Biotech has reported Total Current Liabilities over the past 7 years, most recently at $34.8 million for Q4 2025.

  • For Q4 2025, Total Current Liabilities fell 6.07% year-over-year to $34.8 million; the TTM value through Dec 2025 reached $34.8 million, down 6.07%, while the annual FY2025 figure was $35.3 million, 3.2% down from the prior year.
  • Total Current Liabilities for Q4 2025 was $34.8 million at Burning Rock Biotech, up from $33.0 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $63.1 million in Q1 2022 and troughed at $32.1 million in Q2 2025.
  • A 5-year average of $43.9 million and a median of $41.2 million in 2021 define the central range for Total Current Liabilities.
  • Biggest five-year swings in Total Current Liabilities: surged 59.73% in 2021 and later tumbled 36.77% in 2023.
  • Year by year, Total Current Liabilities stood at $58.2 million in 2021, then decreased by 0.62% to $57.9 million in 2022, then tumbled by 36.77% to $36.6 million in 2023, then grew by 1.35% to $37.1 million in 2024, then decreased by 6.07% to $34.8 million in 2025.
  • Business Quant data shows Total Current Liabilities for BNR at $34.8 million in Q4 2025, $33.0 million in Q3 2025, and $32.1 million in Q2 2025.